Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Pathwork Diagnostics logo — Pioneering molecular diagnostics for oncology with the first...

Pathwork Diagnostics

Pioneering molecular diagnostics for oncology with the first FDA-cleared microarray-based gene expression test to identify challenging tumors.

Founded 2002 Venture round Biotechnology, Health Care

General Information

Company Name Pathwork Diagnostics
Founded Year 2002
Founders / Decision Makers
Team member
Industries Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Pathwork Diagnostics. To contact Pathwork Diagnostics, visit pathworkdx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Pathwork Diagnostics

Pathwork Diagnostics is a biotechnology company based in Redwood City, California, founded in 2002. The company specializes in pioneering molecular diagnostics for oncology, particularly focusing on developing advanced tests for identifying challenging tumors. Notably, Pathwork Diagnostics achieved a significant milestone by obtaining FDA clearance for the Pathwork Tissue of Origin Test for frozen tissue, making it the first microarray-based gene expression test to receive such approval. This test is instrumental in identifying complex tumors, including poorly differentiated, undifferentiated, and metastatic cancer. The company operates within the biotechnology and health care industries, highlighting its commitment to advancing medical diagnostics and personalized treatment in the field of oncology. At present, there is no specific information available regarding Pathwork Diagnostics' recent investment activities or investors. However, the company's focus on groundbreaking molecular diagnostics in oncology positions it at the forefront of innovative technologies that have the potential to significantly impact patient care and outcomes within the realm of cancer treatment.

Taxonomy: molecular diagnostics, oncology, gene expression test, FDA clearance, microarray-based test, tissue of origin test, cancer, metastatic cancer, tumor identification, Redwood City, California, innovation, diagnostic technology

No funding data available for Pathwork Diagnostics yet.

Pathwork Diagnostics Alternatives & Competitors

Pathwork Diagnostics vs
Immunicon
Immunicon

Pioneering cell-based diagnostic solutions to empower physicians with timely and accurate cancer ins...

Series F
Biotechnology, Health Care
Pathwork Diagnostics vs
Elphogene, s.r.o.
Elphogene, s.r.o. Czech Republic

Společnost poskytuje unikátní molekulární test oncoMonitor™ pro sledování průběhu a léčby nádorového...

Seed
6 employees
Biotechnology, Health Care
Pathwork Diagnostics vs
Nucleix Ltd.
Nucleix Ltd. Israel

Developing cancer diagnostic panels based on epigenetic bio markers

72 employees
Biotechnology, Health Care

FAQ About Pathwork Diagnostics

Pioneering molecular diagnostics for oncology with the first FDA-cleared microarray-based gene expression test to identify challenging tumors.
Pathwork Diagnostics was founded in 2002.
Pathwork Diagnostics operates in Biotechnology and Health Care. Its work centres on molecular diagnostics, oncology, gene expression test and FDA clearance.
Top alternatives and competitors to Pathwork Diagnostics include Immunicon, Elphogene, s.r.o., Nucleix Ltd., MultiplexDX International, Emphasys Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pathwork Diagnostics and Immunicon are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Pathwork Diagnostics, https://bouncewatch.com/company/pathwork-diagnostics, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes